Novartis Stock Forecast
NYSE: NVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 3:49 PM ET
NVS analyst consensus
Consensus (12 analysts)
hold
Avg. price target
$155.01+8.40%
- Strong buy 3
- Buy 2
- Hold 6
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Novartis (2026-10-07), 5 rate the stock a buy or strong buy, 6 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $155.01, with a high estimate of $185.00 and a low estimate of $130.00. The average target implies upside of 8.4% from the current price of $143.00.
The spread between the highest and lowest targets is 42.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NVS.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 25% |
| Buy | 2 | 17% |
| Hold | 6 | 50% |
| Sell | 1 | 8% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $130.00 | -9.09% |
| Average target | $155.01 | +8.40% |
| High target | $185.00 | +29.38% |